Hoth Therapeutics, Inc. (HOTH)

CIK 0001711786 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Changes In Stockholders Equity
Consolidated Statements of Operations and Comprehensive Loss (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders Equity (P)
Notes
Commitments and Contingencies
Crypto Assets, At Fair Value
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value of Financial Assets and Liabilities
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
License Agreements
License Agreements and Acquired Patent Applications
—
License and Patent Agreements
Note Receivable
—
Organization and Description of Business Operations
Pay Vs Performance Disclosure
Prepaid Expenses and Other Assets
Prepaid Expenses and Other Current Assets
—
Restatement of Previously Issued Audited and Unaudited Financial Statements
—
Significant Accounting Policies
Stockholders Equity
Subsequent Events
Summary of Significant Accounting Policies